Symbol | Exchange | Currency |
|---|
RenovoRx (RNXT) has filed for up to 1,947,040 share secondary offering by selling stockholders. Shares are issuable upon exercise of warrants.
RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced pancreatic cancer (LAPC), announced...
RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced that Poster #CT084 is presenting detailed, open label,...
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Los Altos, California.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Strong Sell | Sell |
| Technical Indicators | Strong Buy | Buy | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Neutral | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.70 | 7.84 | 7.54 | +0.16 | +2.12% | 43.11M | NYSE | |||
| 19.30 | 19.72 | 19.30 | -0.26 | -1.33% | 3.58K | NYSE | |||
| 109.45 | 110.09 | 108.53 | +0.51 | +0.47% | 1.17M | NYSE | |||
| 0.6854 | 0.7855 | 0.64 | -0.0746 | -9.82% | 2.22M | NASDAQ | |||
| 60.12 | 61.74 | 59.52 | -0.36 | -0.60% | 6.62M | NYSE | |||
| 69.10 | 69.97 | 66.70 | +2.43 | +3.64% | 1.03M | NYSE | |||
| 71.42 | 71.50 | 66.72 | +11.40 | +18.99% | 26.33M | NASDAQ | |||
| 0.637 | 0.665 | 0.625 | -0.013 | -2.00% | 6.46M | NASDAQ | |||
| 88.29 | 89.24 | 88.10 | +0.15 | +0.17% | 12.81M | NYSE | |||
| 18.52 | 18.54 | 18.20 | +0.12 | +0.65% | 95.45K | NYSE | |||
| 130.62 | 134.82 | 126.01 | +3.93 | +3.10% | 2.74M | NASDAQ | |||
| 44.75 | 45.01 | 43.83 | +0.38 | +0.86% | 269.32K | NYSE | |||
| 1.86 | 1.90 | 1.82 | -0.50 | -21.19% | 51.35M | NASDAQ | |||
| 3.38 | 3.99 | 3.31 | -0.67 | -16.54% | 29.14M | NYSE | |||
| 25.39 | 25.41 | 25.38 | -0.01 | -0.04% | 15.90K | NYSE |